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ABSTRACT 
RBC membrane can be affected by consumption of bioactive compounds from herbs and medicinal plants. This study aimed to assess 
hemolytic effect of crude ethyl acetate and acetone extract from Cassia glauca flowers. Both the extracts of Cassia flowers were prepared, 
using Soxhlet apparatus. RBCs were washed with phosphate buffered saline and resuspended in 0.9% normal saline. These RBCs were added 
to different concentrations of the extracts and then incubated. After centrifugation, absorbance of the supernatant was determined by UV 
spectrophotometer at 540 nm. The present work shows that the fractions exhibited anti-hemolytic potential as extracts of Cassia flower 
showed very less percent of hemolysis when compared to standard quercetin. IC50values were found to be 23.77μg/ml for (CF EA) and 
12.50μg/ml for Cassia flower in acetone(CF A)against standard which was found to be 41.75μg/ml. Extracts of Cassia flower exhibited very 
low hemolytic activity. Hence, it can be considered as safe to human RBCs.  In future recommend further in vitro and in vivo studies to 
evaluate the clinical efficacy of Cassia glauca extracts for treated several diseases.  
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1. INTRODUCTION 
Cassia is a genus of flowering plants in the family Fabaceae. 
It has been used as an anti-inflammatory, analgesic, 
laxative, purgative, antimicrobial and anti-ulcerative. It has 
also been used in traditional Brazilian medicine for the 
treatment of flu and cold. In Ayurvedic system of medicine, 
these plants were also used for the treatment of fever and 
headache. 
Hemolysis also known by several other names, is the 
rupturing of red blood cells and the release of their 
contents into surrounding fluid. It may occur in vivo or in 
vitro. Toxicity of active molecule is a key factor during drug 
designing and hemolytic activity represents a useful 
starting point in this regard. Hemolytic activity of any 
compounds is an indicator of general cytotoxicity towards 
normal healthy cells1. 
Many plants contain chemical substances that might have a 
hemolytic or anti-hemolytic effect on human erythrocytes. 
Several reports indicate that the membranes of human 
erythrocytes from blood types have varying stability as 
determined from the mean corpuscular fragility. Plant 
extracts can positively affect the red cell membrane and 
many plants have serious adverse effects, which include 
induction of hemolytic anemia. Therefore, many of the 
commonly used plants need to be evaluated for their 
potential hemolytic activity2. 
 
Cassia Glauca Flower 
Various models exist for evaluation of membrane toxicity 
of surfactants including single cell models using 
erythrocytes, erythrocyte ghosts, or liposomes. The 
erythrocyte model has been widely used as it presents a 
direct indication of toxicity of injectable formulations as 
well as general indication of membrane toxicity. Another 
advantage of erythrocytes model is that blood is readily 
available and that cells are easy to isolate from the blood; 
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moreover, its membrane has similarities with other cell 
membrane3. 
Erythrocytes, which are the most abundant cells in the 
human body, possessing desirable physiological and 
morphological characteristics, are exploited extensively in 
drug delivery. Oxidative damage to the erythrocyte 
membrane (lipid/protein) may be implicated in hemolysis 
associated with some hemoglobinopathies, oxidative 
drugs, transition metal excess, radiation, and deficiencies 
in some erythrocyte antioxidant systems4. 
The half maximal inhibitory concentration (IC50) is a 
measure of the potency of a substance in inhibiting a 
specific biological or biochemical function. This 
quantitative measure indicates how much of a particular 
drug or other substance (inhibitor) is needed to inhibit a 
given biological process (or component of a process, i.e. 
an enzyme, cell, cell receptor or microorganism) by half. 
The values are typically expressed as molar concentration. 
It is commonly used as a measure of antagonist 
drug potency in pharmacological research. According to 
the FDA, IC50 represents the concentration of a drug that is 
required for 50% inhibition in vitro. 
The aim of this study was to screen the ethyl acetate and 
acetone extract of the flower of Cassia glauca, for anti 
hemolytic activity towards human RBCs. 
2. MATERIALS AND METHODS 
2.1 Collection of flower: Cassia flowers were collected 
from nearby local area of Shegaon of Buldhana district. The 
plant material was washed under running tap water to 
remove the surface pollutants and air dried under the 
shade. To complete removal of soil from it, material was 
also dried in incubator at 40º C. Dried sample was 
grounded into a uniform powder using a grinder.The 
extraction was carried out separately by the solvents ethyl 
acetate and acetone until the extract turned to colourless. 
2.2 Preparation of erythrocytes suspension: 
Five milliliters of blood was collected from a healthy 
individual in EDTA vacutainer. The blood was centrifuged 
at 3000 ×g for 10 minutes in a laboratory centrifuge. 
Plasma (supernatant) was discarded and the pellet was 
washed 3-4 times with sterile phosphate buffered saline 
solution (pH 7.2±0.2) by centrifugation at 3000 ×g for 10 
min. The cells were resuspended in 0.9 % normal saline. 
2.3 Anti-hemolytic activity assay:  
In vitro hemolytic activity was performed by 
spectrophotometer method with some modifications 
following the method of Shabbir et al. A volume of 0.5 ml of 
the cell suspension was mixed with 0.5 ml of the plant 
extracts (10, 50, 100, 200 and 250 µg/ml concentrations in 
phosphate buffer saline). The mixtures were incubated for 
30 min at 37˚C in an incubator. The mixture was 
centrifuged at 3000 rpm for 10 min in a laboratory 
centrifuge. The free hemoglobin in the supernatant was 
measured in UV-VIS spectrophotometer at 540 nm. 
Phosphate buffer saline and distilled water were used as 
minimal and maximal hemolytic controls. Each experiment 
was performed in triplicates at each concentration. The 
level of percentage hemolysis by the extracts was 
calculated according to the following formula:  
% Hemolysis = 100 - (Sample/ Control) × 1001,  
 
 
Statistical Analysis: 
All tests were conducted in triplicate. Data are reported as 
means ± standard deviation (n=3). Results were analyzed 
statistically by using Microsoft Excel 2007. 
The IC50 values were calculated using linear trendline, R-
squared equation in excel where the abscissa represented 
the concentration of tested plant extracts and the ordinate 
the average percent of hemolysis. 
3. RESULT AND DISCUSSION 
Erythrocytes are considered as major target for the free 
radicals owing to the presence of both high membrane 
concentration of polyunsaturated fatty acids (PUFA) and 
the oxygen transport associated with redox active 
hemoglobin molecules, which are potent promoters of 
activated oxygen species4. 
In the present study, anti-hemolytic activity of the extracts 
of flowers of Cassia glauca was screened against normal 
human erythrocytes. Cassia flower in ethyl acetate (CF EA) 
and Cassia flower in acetone (CF A) extracts inhibited 
hemolysis with 54.1% and 53.1% anti-hemolytic activity of 
10μg/ml. Percent of hemolysis found to be decreased as 
the concentration increases. These two extracts 
represented the strongest efficiency. 
IC50values were shown to be 41.75μg/ml for standard, 
23.77μg/ml for CF EA and 12.50μg/ml for CF A 
respectively. Result of IC50 revealed that, Cassia flower 
extracts were shown to be low percent of hemolysis at half 
of the concentration in comparison of standard. 
Since red blood cell membrane contains high amount of 
polyunsaturated fatty acids, they are vulnerable to 
oxidative stress. In patients with β-thalassemia, sickle cells 
anemia and renal disease, ROS (Reactive Oxygen Species) 
production is higher than normal7. Thus, this plant might 
be used for preventing harmfulness in many oxidative 
diseases. 
 
Inhibition of Hemolysis in Standard Quercetin 
against Control 
 
Inhibition of Hemolysis in Cassia Flower extracts against 
Control
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Table 1: Percent Hemolysis and IC50 Values of Standard Quercetin and Cassia glauca Flower extracts in different solvents 
Concentration of dried 
extracts in  µg/ml 
STD CF EA CF A 
10 57.3±0.22 54.1±0.21 53.1±0.21 
50 47.2±0.18 45.2±0.18 42.8±0.17 
100 38.1±0.15 35.1±0.14 33.8±0.13 
200 27.2±0.11 26.1±0.10 24.9±0.10 
250 15.1±0.06 14.1±0.05 13.8±0.05 
IC50 in µg/ml 41.75 23.77 12.50 
STD: Standard, CF EA: Cassia Flower Extract in Ethyl acetate, CF A:  Cassia Flower Extract in Acetone. 
 
 
Figure 1: Graph showing percent hemolysis in Standard 
and Cassia flowers 
 
Figure 2: Graphical representation of IC50 values in Cassia 
flower extracts against Standard
 
4. CONCLUSION 
It can be concluded from results that both extracts 
exhibited great anti-hemolytic activity as per the increased 
concentrations. Thus, study revealed that both the extracts 
from the flowers of Cassia glauca are protective to the 
human erythrocytes; lead us to propose that it can be used 
in pharmaceutical fields. The extracts possesses anti- 
hemolytic effect, for this, the further study of this plant 
parts can be suggested before such uses could be proposed 
with confidence which will make it possible to prevent the 
risks of a possible anemia. 
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